Skip to content

Who is the oldest person with progeria?

4 min read

While the average lifespan for a person with progeria is roughly 14 years, medical advancements have allowed some individuals to live much longer. This raises the question: who is the oldest person with progeria?

Quick Summary

The title of the longest-living person with classic progeria goes to Sammy Basso, who passed away in 2024 at age 28. Tiffany Wedekind, now in her mid-40s, is the oldest known survivor of a non-classic form of the condition.

Key Points

  • Oldest Known with Classic Progeria: Sammy Basso, an Italian biologist and activist, passed away at 28 years old in October 2024, holding the record for the longest-living person with classic Hutchinson-Gilford Progeria Syndrome (HGPS).

  • Oldest Known Survivor (Atypical): Tiffany Wedekind, a woman from Ohio in her mid-40s, is the oldest known person living with a progeria-related condition, which is a less severe, atypical form.

  • Classic vs. Atypical Progeria: Classic progeria, like Sammy's, is a distinct genetic mutation causing rapid aging and shorter lifespans, while atypical forms, like Tiffany's, result from different genetic anomalies leading to slower disease progression.

  • Impact on Research: Individuals who live longer with progeria, such as Sammy Basso, have provided invaluable data for researchers, contributing to advancements in understanding the condition and developing treatments like lonafarnib.

  • The Progeria Research Foundation: Organizations like the PRF have been instrumental in supporting individuals with progeria, funding critical research, and raising awareness about the disease.

  • Resilience and Advocacy: Both Sammy Basso and Tiffany Wedekind became powerful advocates, inspiring millions and demonstrating that living with a rare, life-shortening condition does not diminish one's ability to lead a meaningful and impactful life.

In This Article

Remembering Sammy Basso: Longest with Classic Progeria

For many years, the record for the oldest person with classic progeria was held by Sammy Basso. An Italian biologist, activist, and researcher, Sammy defied expectations by living to the age of 28. He sadly passed away in October 2024, but not before leaving an indelible mark on the scientific community and the global progeria community.

Sammy was a long-time ambassador for the Progeria Research Foundation (PRF) and a passionate advocate for finding a cure. His extraordinary zest for life, optimism, and brilliant mind inspired millions. He participated in PRF's clinical trials from a young age and later pursued a master's degree in molecular biology, using his knowledge to contribute directly to gene-editing research aimed at treating progeria.

His remarkable journey was documented in a National Geographic series, showcasing his love for adventure and his determination to live life to the fullest. Sammy's legacy is a testament to the resilience of the human spirit and the potential for extended lifespans through dedicated research and advocacy.

Meet Tiffany Wedekind: The Oldest Known Survivor

While Sammy Basso holds the record for classic progeria, Tiffany Wedekind from Columbus, Ohio, is recognized as the oldest known survivor of a progeria-related condition. As of 2023, Tiffany was 45 years old, a fact that has baffled medical professionals for years. Her remarkable resilience and positive outlook have made her a well-known speaker and advocate.

Tiffany's case is particularly unique because she was not diagnosed with the condition until age 31. She carries a less severe form of the genetic disorder, a trait also shared by her late mother, who lived to be 75. This highlights the spectrum of progeria-related diseases, which can manifest with varying severity and progression rates.

Despite facing significant health challenges, including cardiovascular disease and severe arthritis, Tiffany continues to live an inspiring and active life. She is a powerful symbol of hope, demonstrating that life can be lived fully and vibrantly, regardless of the physical limitations imposed by a rare condition.

Classic Progeria vs. Atypical Progeria: Understanding the Differences

The cases of Sammy Basso and Tiffany Wedekind illustrate a crucial distinction within the progeria spectrum. The vast majority of cases, including Sammy's, are considered classic Hutchinson-Gilford Progeria Syndrome (HGPS). This is caused by a specific and spontaneous mutation in the LMNA gene, which creates a protein called progerin. This toxic protein leads to the rapid aging and a shortened lifespan. Most classic HGPS patients do not live past their mid-teens.

In contrast, atypical progeria syndromes result from different mutations in the same LMNA gene or related genes. These mutations can produce slightly different toxic proteins or have less severe effects, leading to a slower progression of the disease and a longer life expectancy. Tiffany's case, like her mother's, falls into this category, with a variant that was less severe and allowed for a much longer survival.

A Comparison of Noted Progeria Survivors

Feature Sammy Basso (Classic HGPS) Tiffany Wedekind (Atypical Progeria)
Lifespan Passed away at age 28 (longest with classic HGPS) 45+ years old (oldest known survivor)
Condition Classic Hutchinson-Gilford Progeria Syndrome Atypical Progeria Syndrome
Onset of Diagnosis Early childhood Diagnosed at age 31
Known Relatives with Condition None specified Mother also had a less severe form
Advocacy PRF Ambassador, molecular biology researcher Speaker, advocate, runs a yoga/art collective

The Impact of Medical Advancements on Progeria Lifespan

The existence of individuals like Sammy and Tiffany underscores the profound impact of medical research on rare diseases. Advances in treatment, such as the drug lonafarnib, have demonstrated an ability to slow the progression of progeria and extend lifespans. This work is largely driven by organizations like the Progeria Research Foundation, which have been pivotal in funding research and connecting patients with clinical trials.

Additionally, these individuals have enabled a deeper understanding of the genetic mechanisms behind progeria, which can provide insights not only into this specific disorder but into the general aging process. Their participation in research has been invaluable for scientists working toward a cure.

The Role of Advocacy and Awareness

The stories of individuals with progeria are not just medical case studies; they are powerful narratives of hope and perseverance. Through advocacy and sharing their personal stories, they have raised global awareness about this rare condition, helping to secure funding for research and inspire future generations of scientists. Figures like Sammy Basso and Tiffany Wedekind have put a human face to the disease, demonstrating that those with progeria are defined not by their diagnosis but by their vibrant spirits and determination.

For more information on the latest research and to support the ongoing fight for a cure, please visit the Progeria Research Foundation.

Conclusion: Pushing the Boundaries of Longevity

The question of who is the oldest person with progeria reveals a complex and inspiring story. It highlights both the tragedy of classic HGPS and the remarkable outliers who defy the odds. Sammy Basso’s life, while tragically cut short, pushed the known boundaries of classic progeria longevity. At the same time, Tiffany Wedekind continues to live a life that proves resilience and determination can overcome even the most challenging circumstances. Their stories offer hope that with continued scientific advancement, we can push the boundaries of what is possible for those living with progeria and other rare genetic disorders.

Frequently Asked Questions

The oldest known person with classic progeria was Sammy Basso, an Italian scientist and advocate who passed away in October 2024 at the age of 28.

Yes, as of recent reports, Tiffany Wedekind is the oldest known survivor of a progeria-related condition, living in her mid-40s. Her condition is an atypical, less severe form.

The average life expectancy for a person with classic Hutchinson-Gilford Progeria Syndrome (HGPS) is about 14.5 years, though this can be extended with recent medical treatments.

Classic progeria (HGPS) results from a specific mutation causing rapid aging and a shortened lifespan. Atypical progeria, caused by different mutations, has a slower progression, allowing for a longer lifespan.

Progeria is caused by a genetic mutation in the LMNA gene. In classic progeria, this mutation leads to the production of a toxic protein called progerin.

While there is no cure, the FDA has approved the drug lonafarnib to reduce the risk of mortality in children with progeria. Clinical trials are also ongoing to further improve treatments.

Progeria is extremely rare. It is estimated to affect one in four to eight million newborns worldwide, and there are only a few hundred known cases at any given time.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.